Physician profile
Mohammad Abbasian
NPI 1285693879
$2,692.37
in general payments reported to CMS, 2019-2025
14 companies · $47.37 in 2025
The $47.37 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.73 · 2020: $1,644 · 2021: $68.53 · 2022: $763 · 2024: $145 · 2025: $47.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $1,375.00 | 2020 | |
| Cgg Medical INC | $357.57 | 2022 | |
| Vertos Medical, INC. | $323.56 | 2022 | |
| Medtronic USA, INC. | $147.30 | 2020 | |
| Abbott Laboratories | $128.06 | 2019-2024 | Proclaim |
| Relievant Medsystems, INC. | $107.95 | 2020 | |
| Boston Scientific Corporation | $104.30 | 2021-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $50.00 | 2022 | |
| Medtronic, INC. | $24.75 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.55 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.26 | 2022 | |
| Stimwave Technologies Incorporated | $13.95 | 2020 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Abbasian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.